Europe — EMA
Noradrenalina B. Braun (Noradrenaline Tartrate)
GNH USA supplies Noradrenalina B. Braun (Norepinephrine), a sympathomimetic vasopressor for acute hypotension, septic shock and cardiac arrest.
Request sourcing
What is Noradrenaline Tartrate?
Norepinephrine, the active ingredient in Noradrenalina B. Braun, is a sympathomimetic (vasopressor) presented as an injection solution for intravenous use. It is employed to raise blood pressure and improve cardiac output in patients experiencing acute hypotensive states, such as septic or cardiogenic shock, and during cardiac arrest.
GNH USA supplies Noradrenalina B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and provides reliable logistics for global healthcare facilities.
What is Noradrenaline Tartrate used for?
Noradrenalina B. Braun is used in critical care settings to manage severe hypotension and shock states.
Acute hypotension: restores arterial pressure by inducing peripheral vasoconstriction. Septic shock: supports circulatory function and organ perfusion during systemic infection. Cardiogenic shock: enhances cardiac output while maintaining systemic vascular resistance. Cardiac arrest: provides immediate pressor support to facilitate resuscitation efforts.
What are the side effects of Noradrenaline Tartrate?
Administration of norepinephrine may be associated with a range of adverse reactions, varying from mild to severe.
Common Side Effects: - Headache: transient discomfort due to rapid blood pressure changes. - Tachycardia: increased heart rate secondary to beta‑1 stimulation. - Peripheral ischemia: reduced blood flow to extremities causing coldness or discoloration. - Nausea: gastrointestinal upset often related to catecholamine surge.
Serious or Rare Side Effects: - Severe hypertension: excessive rise in blood pressure that may precipitate stroke. - Myocardial ischemia: reduced coronary perfusion leading to chest pain or infarction. - Tissue necrosis: extravasation of the drug causing local tissue damage. - Life‑threatening arrhythmias: abnormal heart rhythms that can progress to cardiac arrest.
What precautions apply to Noradrenaline Tartrate?
When using Noradrenalina B. Braun, clinicians should observe several safety considerations to minimize risk.
Dose titration: adjust infusion rate to achieve target blood pressure while avoiding overshoot. Cardiac monitoring: continuous ECG and hemodynamic monitoring are required during infusion. Extravasation risk: monitor the infusion site closely and discontinue if infiltration is suspected. Concomitant drugs: evaluate interactions with MAO inhibitors, beta‑blockers, and other vasopressors. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Noradrenaline Tartrate interact with?
Norepinephrine can interact with other medications, influencing its efficacy or safety profile.
Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis. - Tricyclic antidepressants: additive pressor effect increasing risk of severe hypertension. - Beta‑blockers: can blunt the desired increase in heart rate and cardiac output.
Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may reduce the pressor effect of norepinephrine. - Calcium channel blockers: can alter vascular tone and affect blood pressure response. - Anesthetic agents (e.g., halothane): may potentiate hypotension and require careful dose adjustment.
